Skip to main content
SpringerLink
Log in

Invention and uptake of TAVI over the first 20 years

  • World View
  • Published:

From Nature Reviews Cardiology

View current issue Sign up to alerts

Transcatheter aortic valve implantation (TAVI) is a breakthrough technology to replace the aortic valve in patients with severe aortic stenosis using simple cardiac catheterization instead of thoracic surgery. Initiated 20 years ago by my colleagues and me, TAVI has been performed in >1.5 million patients globally and has profoundly altered the landscape of cardiovascular medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lababidi, Z., Wu, J. R. & Walls, J. T. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am. J. Cardiol. 53, 194–197 (1984).

    Article  CAS  Google Scholar 

  2. Cribier, A. et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1, 63–67 (1986).

    Article  CAS  Google Scholar 

  3. Eltchaninoff, H. et al. Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency. EuroIntervention 1, 438–444 (2006).

    PubMed  Google Scholar 

  4. Cribier, A. et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006–3008 (2002).

    Article  Google Scholar 

  5. Cribier, A. et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol. 47, 1214–1223 (2006).

    Article  Google Scholar 

  6. Webb, J. G. et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113, 842–850 (2006).

    Article  Google Scholar 

  7. Walther, T. et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur. J. Cardiothorac. Surg. 33, 983–988 (2008).

    Article  Google Scholar 

  8. Grube, E. et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69–76 (2007).

    Article  Google Scholar 

  9. Vahanian, A. et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561–632 (2022).

    Article  Google Scholar 

  10. Durand, E. et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc. Interv. 5, 461–467 (2012).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Charles Nicolle Hospital, University of Rouen, Rouen, France

    Alain Cribier

Authors
  1. Alain Cribier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alain Cribier.

Ethics declarations

Competing interests

A.C. is a consultant for Edwards Lifesciences.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cribier, A. Invention and uptake of TAVI over the first 20 years. Nat Rev Cardiol 19, 427–428 (2022). https://doi.org/10.1038/s41569-022-00721-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41569-022-00721-w

  • Springer Nature Limited

This article is cited by

Search

Navigation